All Categories / Oncology

Oncology Journals

Browse 170 journals in Oncology. Click on any journal to view complete submission guidelines, formatting requirements, and more.

View top Oncology journals by impact factor
CC
Ca-a Cancer Journal For Clinicians

WILEY

IF: 232.4
Q1
Hybrid
NR
Nature Reviews Clinical Oncology

NATURE PORTFOLIO

IF: 82.2
Q1
Hybrid
NR
Nature Reviews Cancer

NATURE PORTFOLIO

IF: 66.8
Q1
Hybrid
AO
Annals Of Oncology

Elsevier BV

IF: 65.4
Q1
Hybrid
CC
Cancer Cell

CELL PRESS

IF: 44.5
Q1
Hybrid
JO
Journal Of Clinical Oncology

LIPPINCOTT WILLIAMS & WILKINS

IF: 41.9
Q1
Hybrid
JO
Journal Of Hematology & Oncology

BioMed Central

IF: 40.4
Q1
Open
LO
Lancet Oncology

Elsevier BV

IF: 35.9
Q1
Hybrid
MC
Molecular Cancer

BioMed Central

IF: 33.9
Q1
Open
CD
Cancer Discovery

American Association for Cancer Research

IF: 33.3
Q1
Closed
NC
Nature Cancer

NATURE PORTFOLIO

IF: 28.5
Q1
Hybrid
CC
Cancer Communications

WILEY

IF: 24.9
Q1
Open
JO
Journal Of Thoracic Oncology

Elsevier BV

IF: 20.8
Q1
Hybrid
JO
JAMA Oncology

American Medical Association

IF: 20.1
Q1
Closed
TI
Trends In Cancer

Elsevier BV

IF: 17.5
Q1
Hybrid
CR
Cancer Research

American Association for Cancer Research

IF: 16.6
Q1
Open
JO
Journal Of The National Comprehensive Cancer Network

National Comprehensive Cancer

IF: 16.4
Q1
Closed
SI
Seminars In Cancer Biology

Elsevier BV

IF: 15.7
Q1
Hybrid
EH
Experimental Hematology & Oncology

BioMed Central

IF: 13.5
Q1
Open
Le
Leukemia

Springer Nature

IF: 13.4
Q1
Hybrid
Ne
Neuro-oncology

Oxford University Press

IF: 13.4
Q1
Hybrid
JC
Jacc: Cardiooncology

Elsevier BV

IF: 12.8
Q1
Open
JO
Journal Of Experimental & Clinical Cancer Research

BioMed Central

IF: 12.8
Q1
Open
BC
Blood Cancer Journal

Springer Nature

IF: 11.6
Q1
Open
BC
Blood Cancer Discovery

American Association for Cancer Research

IF: 11.5
Q1
Hybrid
BR
Biomarker Research

BioMed Central

IF: 11.5
Q1
Open
JF
Journal For Immunotherapy Of Cancer

BMJ

IF: 10.6
Q1
Open
CT
Cancer Treatment Reviews

Elsevier BV

IF: 10.5
Q1
Hybrid
CC
Clinical Cancer Research

American Association for Cancer Research

IF: 10.2
Q1
Closed
CL
Cancer Letters

Elsevier BV

IF: 10.1
Q1
Hybrid
JO
Journal Of The National Cancer Center

Elsevier BV

IF: 9.4
Q1
Open
EU
European Urology Oncology

Elsevier BV

IF: 9.3
Q1
Hybrid
LC
Liver Cancer

Karger Publishers

IF: 9.1
Q1
Hybrid
CA
Cancer And Metastasis Reviews

Springer Science+Business Media

IF: 8.7
Q1
Hybrid
CB
Cancer Biology & Medicine

Chinese Anti-Cancer Association

IF: 8.4
Q1
Open
BE
Biochimica Et Biophysica Acta-reviews On Cancer

Elsevier BV

IF: 8.3
Q1
Hybrid
EO
Esmo Open

Elsevier BV

IF: 8.3
Q1
Open
NP
Npj Precision Oncology

NATURE PORTFOLIO

IF: 8
Q1
Open
Br
Breast

Elsevier BV

IF: 7.9
Q1
Open
Ne
Neoplasia

Elsevier BV

IF: 7.7
Q1
Open
NB
Npj Breast Cancer

NATURE PORTFOLIO

IF: 7.6
Q1
Open
JO
Jnci-journal Of The National Cancer Institute

Oxford University Press

IF: 7.2
Q1
Hybrid
EJ
European Journal Of Cancer

Elsevier BV

IF: 7.1
Q1
Closed
Bi
Biodrugs

Adis, Springer Healthcare

IF: 6.9
Q1
Hybrid
BJ
British Journal Of Cancer

Springer Nature

IF: 6.8
Q1
Hybrid
CA
Clinical And Translational Medicine

Springer Science+Business Media

IF: 6.8
Q1
Open
IJ
International Journal Of Radiation Oncology Biology Physics

Elsevier BV

IF: 6.5
Q1
Hybrid
On
Oncogenesis

Springer Nature

IF: 6.4
Q1
Open
On
Oncoimmunology

Landes Bioscience

IF: 6.3
Q1
Open
CJ
Chinese Journal Of Cancer Research

AME PUBLISHING COMPANY

IF: 6.3
Q1
Open
RC
Radiology-imaging Cancer

Radiological Society of North America

IF: 6.3
Q1
Hybrid
AR
Annual Review Of Cancer Biology

ANNUAL REVIEWS

IF: 6.1
Q1
Open
CC
Cancer Cell International

BioMed Central

IF: 6
Q1
Open
PC
Prostate Cancer And Prostatic Diseases

Springer Nature

IF: 5.8
Q1
Hybrid
BC
Breast Cancer Research

BioMed Central

IF: 5.6
Q1
Open
CR
Critical Reviews In Oncology Hematology

Elsevier BV

IF: 5.6
Q1
Hybrid
JP
JCO Precision Oncology

LIPPINCOTT WILLIAMS & WILKINS

IF: 5.6
Q1
Open
MC
Molecular Cancer Therapeutics

American Association for Cancer Research

IF: 5.5
Q1
Closed
RA
Radiotherapy And Oncology

Elsevier BV

IF: 5.3
Q1
Hybrid
MT
Molecular Therapy Oncology

CELL PRESS

IF: 5.3
Q1
Open
C&
Cancer & Metabolism

BioMed Central

IF: 5.3
Q1
Open
JO
Journal Of Pathology

WILEY

IF: 5.2
Q1
Hybrid
BM
Bone Marrow Transplantation

Springer Nature

IF: 5.2
Q1
Hybrid
OR
Oncology Reviews

PAGEPress (Italy)

IF: 5.2
Q1
Open
CD
Cancer Drug Resistance

OAE PUBLISHING INC

IF: 5.2
Q1
Open
CI
Cancer Immunology Immunotherapy

Springer Science+Business Media

IF: 5.1
Q1
Open
GC
Gastric Cancer

Springer Science+Business Media

IF: 5.1
Q1
Hybrid
CO
Current Oncology Reports

Springer Science+Business Media

IF: 5
Q1
Hybrid
CG
Cancer Gene Therapy

Springer Nature

IF: 5
Q1
Hybrid
IJ
International Journal Of Oncology

Spandidos Publishing

IF: 4.9
Q1
Open
BA
Blood And Lymphatic Cancer-targets And Therapy

Dove Medical Press

IF: 4.9
Q1
Open
CO
Cellular Oncology

Springer Nature

IF: 4.8
Q1
Open
CN
Cancer Nanotechnology

BioMed Central

IF: 4.8
Q1
Open
IJ
International Journal Of Cancer

WILEY

IF: 4.7
Q1
Hybrid
IJ
International Journal Of Gynecological Cancer

BMJ

IF: 4.7
Q1
Hybrid
MC
Molecular Cancer Research

American Association for Cancer Research

IF: 4.7
Q1
Hybrid
CT
Current Treatment Options In Oncology

Springer Science+Business Media

IF: 4.7
Q1
Hybrid
CB
Cancer Biology & Therapy

Taylor & Francis

IF: 4.6
Q1
Hybrid
EC
Endocrine-related Cancer

Bioscientifica

IF: 4.6
Q1
Hybrid
JO
Jco Oncology Practice

LIPPINCOTT WILLIAMS & WILKINS

IF: 4.6
Q1
Hybrid
MO
Molecular Oncology

Elsevier BV

IF: 4.5
Q2
Open
CE
Clinical Epigenetics

BioMed Central

IF: 4.4
Q1
Open
Ca
Cancers

Multidisciplinary Digital Publishing Institute

IF: 4.4
Q2
Open
CS
Cancer Science

WILEY

IF: 4.3
Q2
Open
On
Oncologist

AlphaMed Press

IF: 4.2
Q2
Hybrid
TA
Therapeutic Advances In Medical Oncology

SAGE Publishing

IF: 4.2
Q2
Open
GO
Gynecologic Oncology

Elsevier BV

IF: 4.1
Q1
Hybrid
TO
Translational Oncology

Elsevier BV

IF: 4.1
Q2
Open
OR
Oncology Research

Cognizant Communication Corporation

IF: 4.1
Q2
Open
RP
Recent Patents On Anti-cancer Drug Discovery

Bentham Science Publishers

IF: 4.1
Q2
Open
NA
Neuro-oncology Advances

Oxford University Press

IF: 4.1
Q1
Hybrid
JC
JNCI Cancer Spectrum

Oxford University Press

IF: 4.1
Q2
Hybrid
TO
Targeted Oncology

Adis, Springer Healthcare

IF: 4
Q2
Hybrid
OR
Oncology Reports

Elsevier BV

IF: 3.9
Q2
Hybrid
OO
Oral Oncology

Elsevier BV

IF: 3.9
Q1
Hybrid
HO
Hematological Oncology

WILEY

IF: 3.9
Q1
Hybrid
CR
Cancer Research And Treatment

KOREAN CANCER ASSOCIATION

IF: 3.8
Q2
Open
JO
Journal Of Gastric Cancer

KOREAN GASTRIC CANCER ASSOC

IF: 3.8
Q2
Open
JO
Journal Of Gynecologic Oncology

Korean Society of Gynecologic Oncology

IF: 3.7
Q1
Open
SC
Stem Cells

Oxford University Press

IF: 3.6
Q2
Closed
JO
Journal Of Mammary Gland Biology And Neoplasia

Springer Science+Business Media

IF: 3.6
Q2
Open
AO
Annals Of Surgical Oncology

Springer Science+Business Media

IF: 3.5
Q2
Hybrid
MM
Molecular Medicine Reports

Spandidos Publishing

IF: 3.5
Q2
Hybrid
EC
Experimental Cell Research

Elsevier BV

IF: 3.5
Q2
Hybrid
Ps
Psycho-oncology

WILEY

IF: 3.5
Q2
Hybrid
MO
Medical Oncology

Springer Science+Business Media

IF: 3.5
Q2
Hybrid
TL
Translational Lung Cancer Research

AME PUBLISHING COMPANY

IF: 3.5
Q2
Open
CI
Cancer Imaging

BioMed Central

IF: 3.5
Q2
Open
PR
Practical Radiation Oncology

Elsevier BV

IF: 3.5
Q2
Hybrid
CC
Current Cancer Drug Targets

Bentham Science Publishers

IF: 3.5
Q2
Hybrid
FO
Frontiers Of Medicine

Higher Education Press

IF: 3.5
Q2
Hybrid
JC
Jto Clinical And Research Reports

Elsevier BV

IF: 3.5
Q2
Open
JO
Journal Of Bone Oncology

Elsevier BV

IF: 3.5
Q2
Open
CE
Cancer Epidemiology Biomarkers & Prevention

American Association for Cancer Research

IF: 3.4
Q2
Hybrid
CO
Current Oncology

Multidisciplinary Digital Publishing Institute

IF: 3.4
Q2
Open
BC
Breast Cancer-targets And Therapy

Dove Medical Press

IF: 3.4
Q2
Open
BC
Bmc Cancer

BioMed Central

IF: 3.4
Q2
Open
JO
Journal Of Hepatocellular Carcinoma

Dove Medical Press

IF: 3.4
Q2
Open
FI
Frontiers In Oncology

Frontiers Media

IF: 3.3
Q2
Open
CL
Clinical Lung Cancer

Elsevier BV

IF: 3.3
Q2
Hybrid
CH
Current Hematologic Malignancy Reports

Springer Science+Business Media

IF: 3.3
Q2
Hybrid
P&
Physics & Imaging In Radiation Oncology

Elsevier BV

IF: 3.3
Q2
Open
CR
Cancer Research Communications

American Association for Cancer Research

IF: 3.3
Q2
Open
LC
Lung Cancer-targets And Therapy

Dove Medical Press

IF: 3.3
Q2
Hybrid
JO
Journal Of Cancer

Ivyspring International Publisher

IF: 3.2
Q2
Open
MC
Molecular Carcinogenesis

WILEY

IF: 3.2
Q2
Hybrid
C&
Clinical & Experimental Metastasis

Springer Science+Business Media

IF: 3.2
Q2
Hybrid
CC
Cancer Cytopathology

WILEY

IF: 3.2
Q2
Hybrid
SI
Seminars In Radiation Oncology

Elsevier BV

IF: 3.2
Q2
Hybrid
CC
Clinical Colorectal Cancer

Elsevier BV

IF: 3.2
Q2
Hybrid
NC
Nar Cancer

Oxford University Press

IF: 3.2
Q2
Hybrid
OA
Oncology And Therapy

Adis, Springer Healthcare

IF: 3.2
Q2
Open
JO
Journal Of Immunotherapy And Precision Oncology

Innovative Healthcare Institute

IF: 3.2
Q2
Closed
RO
Radiation Oncology

BioMed Central

IF: 3.2
Q2
Open
Ca
Cardio-oncology

BioMed Central

IF: 3.2
Q2
Open
CM
Cancer Medicine

WILEY

IF: 3.1
Q2
Open
JO
Journal Of Neuro-oncology

Springer Science+Business Media

IF: 3.1
Q2
Hybrid
TJ
Tumori Journal

SAGE Publishing

IF: 3.1
Q2
Hybrid
SC
Supportive Care In Cancer

Springer Science+Business Media

IF: 3
Q2
Hybrid
BC
Breast Cancer Research And Treatment

Springer Science+Business Media

IF: 3
Q2
Hybrid
IJ
International Journal Of Hyperthermia

Taylor & Francis

IF: 3
Q2
Hybrid
AA
Anti-cancer Agents In Medicinal Chemistry

Bentham Science Publishers

IF: 3
Q2
Open
CO
Clinical Oncology

Elsevier BV

IF: 3
Q2
Hybrid
BT
Brain Tumor Pathology

Springer Science+Business Media

IF: 3
Q2
Hybrid
IJ
International Journal Of Breast Cancer

Hindawi Publishing Corporation

IF: 3
Q2
Open
JG
Jco Global Oncology

LIPPINCOTT WILLIAMS & WILKINS

IF: 3
Q2
Open
AI
Advances In Cancer Biology-metastasis

Elsevier BV

IF: 3
Q2
Open
Ca
Carcinogenesis

Oxford University Press

IF: 2.9
Q2
Hybrid
Ej
Ejso

Elsevier BV

IF: 2.9
Q2
Hybrid
AJ
American Journal Of Cancer Research

e-Century Publishing Corporation

IF: 2.9
Q2
Closed
JO
Journal Of Cancer Survivorship

Springer Science+Business Media

IF: 2.9
Q2
Hybrid
BC
Breast Cancer

Springer Science+Business Media

IF: 2.9
Q1
Hybrid
JO
Journal Of Immunotherapy

LIPPINCOTT WILLIAMS & WILKINS

IF: 2.9
Q3
Hybrid
DO
Discover Oncology

Springer Nature

IF: 2.9
Q3
Open
OA
Oncotargets And Therapy

Dove Medical Press

IF: 2.8
Q2
Open
JO
Journal Of Cancer Research And Clinical Oncology

Springer Science+Business Media

IF: 2.8
Q2
Open
IJ
International Journal Of Clinical Oncology

Springer Science+Business Media

IF: 2.8
Q2
Hybrid
TI
Technology In Cancer Research & Treatment

SAGE Publishing

IF: 2.8
Q2
Hybrid
GC
Genes Chromosomes & Cancer

WILEY

IF: 2.8
Q2
Hybrid
IC
Integrative Cancer Therapies

SAGE Publishing

IF: 2.8
Q2
Hybrid
IA
Infectious Agents And Cancer

BioMed Central

IF: 2.8
Q3
Open
CP
Cancer Pathogenesis And Therapy

Elsevier BV

IF: 2.8
Q2
Open
TI
Technical Innovations & Patient Support In Radiation Oncology

Elsevier BV

IF: 2.8
Q2
Open
EJ
European Journal Of Oncology Nursing

Elsevier BV

IF: 2.7
Q1
Hybrid
PC
Pigment Cell & Melanoma Research

WILEY

IF: 2.6
Q2
Hybrid
CN
Cancer Nursing

LIPPINCOTT WILLIAMS & WILKINS

IF: 2.5
Q1
Closed
TC
Thoracic Cancer

WILEY

IF: 2.3
Q3
Open
JO
Journal Of Chemotherapy

Taylor & Francis

IF: 1.8
Q3
Hybrid
AR
Anticancer Research

International Institute of Anticancer Research (IIAR) Conferences 1997. Athens, Greece. Abstracts

IF: 1.7
Q4
Closed
AJ
American Journal Of Translational Research

e-Century Publishing Corporation

IF: 1.6
Q3
Open
Related Categories
Pharmacology & Pharmacy (165)
Public, Environmental & Occupational Health (136)
Clinical Neurology (127)
Infectious Diseases (116)
Immunology (110)
Endocrinology & Metabolism (105)
Respiratory System (95)
Cardiac & Cardiovascular Systems (91)
Preparing a Manuscript?

Use our Journal Finder to search and filter across all specialties by impact factor, quartile, and more.

Try Livewrite to write, edit, cite, and automatically format your manuscript for any journal - all directly inside Microsoft Word.